CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 4 of 2
Non-Antibody Products
Page 4 of 2,593
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 1 mg | 17358-1 | More Info |
| A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 10 mg | 17358-10 | More Info |
| A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 5 mg | 17358-5 | More Info |
| A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 1 mg | 17382-1 | More Info |
| A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 10 mg | 17382-10 | More Info |
| A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 25 mg | 17382-25 | More Info |
| A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 5 mg | 17382-5 | More Info |
| A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 1 mg | 18715-1 | More Info |
| A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 10 mg | 18715-10 | More Info |
| A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 5 mg | 18715-5 | More Info |
| A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 500 µg | 18715-500 | More Info |
| A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 1 mg | 29972-1 | More Info |
| A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 10 mg | 29972-10 | More Info |
| A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 5 mg | 29972-5 | More Info |
| A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 500 µg | 29972-500 | More Info |
| A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 1 mg | 21256-1 | More Info |
| A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 10 mg | 21256-10 | More Info |
| A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 25 mg | 21256-25 | More Info |
| A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 5 mg | 21256-5 | More Info |
| A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 10 mg | 11900-10 | More Info |
| A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 25 mg | 11900-25 | More Info |
| A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 5 mg | 11900-5 | More Info |
| A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 50 mg | 11900-50 | More Info |
| A-770041 | An orally bioavailable LCK kinase inhibitor (IC50 = 0.147 µM); selec… | 1 mg | 32854-1 | More Info |
| A-770041 | An orally bioavailable LCK kinase inhibitor (IC50 = 0.147 µM); selec… | 5 mg | 32854-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile